title: A real time quantitative PCR analysis and correlation of COX-1 and COX-2 enzymes in inflamed dental pulps following administration of three different NSAIDs.
abstract: Dental pain is encountered daily by clinicians. Nonsteroidal anti-inflammatory drugs (NSAIDs) commonly used for pain management are traditionally cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2) inhibitors, and more recently selective COX-2 inhibitors. This study was designed to identify and quantify COX-1 and COX-2 gene expression level in inflamed rat molar pulps after administration of three NSAIDs: Celebrex, Vioxx, and Advil. Fifty male Wistar rats had their first and second molar pulps exposed and sealed with Cavit for 4 days. Rats were randomly divided into the three drug groups and two control groups. RNA was isolated from the rat pulps. Real Time Quantitative Reverse Transcriptase-Polymerase Chain Reaction assay, a relatively new PCR technique, was used to quantify COX-1 and COX-2 mRNA. Statistical analysis demonstrated no significant differences in COX-1 and COX-2 levels among the drug groups. However, Vioxx and Advil significantly reduced COX-2 expression levels compared to inflamed (positive control) pulps (p < 0.05).
authors.affiliation: Department of Endodontics and Periodontics, University of Texas Dental, Branch at Houston, Houston, Texas, USA.
authors.forename: Claudia I
authors.initials: CI
authors.lastname: Holt
authors.forename: Max O
authors.initials: MO
authors.lastname: Hutchins
authors.forename: Roberta
authors.initials: R
authors.lastname: Pileggi
mesh_terms: D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D000068579:Celecoxib; D051545:Cyclooxygenase 1 / Q000032:analysis* / Q000187:drug effects / Q000235:genetics; D051546:Cyclooxygenase 2 / Q000032:analysis* / Q000187:drug effects / Q000235:genetics; D016861:Cyclooxygenase Inhibitors / Q000627:therapeutic use*; D003789:Dental Pulp Exposure / Q000201:enzymology; D007052:Ibuprofen / Q000627:therapeutic use; D007783:Lactones / Q000627:therapeutic use; D008297:Male; D011671:Pulpitis / Q000201:enzymology*; D011720:Pyrazoles / Q000627:therapeutic use; D012333:RNA, Messenger / Q000032:analysis; D011897:Random Allocation; D051381:Rats; D017208:Rats, Wistar; D020133:Reverse Transcriptase Polymerase Chain Reaction; D013449:Sulfonamides / Q000627:therapeutic use; D013450:Sulfones / Q000627:therapeutic use
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D016861:Cyclooxygenase Inhibitors; D007783:Lactones; D011720:Pyrazoles; D012333:RNA, Messenger; D013449:Sulfonamides; D013450:Sulfones; C116926:rofecoxib; D051545:Cyclooxygenase 1; D051546:Cyclooxygenase 2; D000068579:Celecoxib; D007052:Ibuprofen